These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 25273374)

  • 1. Ecteinascidins. A review of the chemistry, biology and clinical utility of potent tetrahydroisoquinoline antitumor antibiotics.
    Le VH; Inai M; Williams RM; Kan T
    Nat Prod Rep; 2015 Feb; 32(2):328-47. PubMed ID: 25273374
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of Yondelis (trabectedin, ET-743). A semisynthetic process solves the supply problem.
    Cuevas C; Francesch A
    Nat Prod Rep; 2009 Mar; 26(3):322-37. PubMed ID: 19240944
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Trabectedin: Ecteinascidin 743, Ecteinascidin-743, ET 743, ET-743, NSC 684766.
    Drugs R D; 2006; 7(5):317-28. PubMed ID: 16922593
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The potent anticancer compound ecteinascidin-743 (ET-743) as its 2-propanol disolvate.
    Sainz-Diaz CI; Manzanares I; Francesch A; Garcia-Ruiz J
    Acta Crystallogr C; 2003 Apr; 59(Pt 4):O197-8. PubMed ID: 12682407
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthetic studies on ecteinascidin-743: constructing a versatile pentacyclic intermediate for the synthesis of ecteinascidins and saframycins.
    Jin W; Metobo S; Williams RM
    Org Lett; 2003 Jun; 5(12):2095-8. PubMed ID: 12790537
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Important classes of bioactive alkaloids from marine ascidians: structures, isolation and bioactivity.
    Menna M
    Curr Top Med Chem; 2014; 14(2):207-23. PubMed ID: 24359200
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Some hope from marine natural products.
    D'Incalci M
    Ann Oncol; 1998 Sep; 9(9):937-8. PubMed ID: 9818065
    [No Abstract]   [Full Text] [Related]  

  • 8. Recent synthetic approaches to 6,15-iminoisoquino[3,2-b]3-benzazocine compounds.
    Avendaño C; de la Cuesta E
    Chemistry; 2010 Aug; 16(32):9722-34. PubMed ID: 20533463
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chemical Research on Antitumor Isoquinoline Marine Natural Products and Related Compounds.
    Saito N
    Chem Pharm Bull (Tokyo); 2021; 69(2):155-177. PubMed ID: 33518599
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A review of trabectedin (ET-743): a unique mechanism of action.
    D'Incalci M; Galmarini CM
    Mol Cancer Ther; 2010 Aug; 9(8):2157-63. PubMed ID: 20647340
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structure elucidation and 1H/13C NMR spectral assignments of four trabectedin related compounds.
    Vermeulen W; Filliers W; García C; Manzanaro S; Montalvo D; Polanco C; Spillemaeckers F; Van Hoof B; Winderickx G; Somers I; Rodriguez-Campos I
    Magn Reson Chem; 2008 Dec; 46(12):1198-202. PubMed ID: 18821578
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Meta-omic characterization of the marine invertebrate microbial consortium that produces the chemotherapeutic natural product ET-743.
    Rath CM; Janto B; Earl J; Ahmed A; Hu FZ; Hiller L; Dahlgren M; Kreft R; Yu F; Wolff JJ; Kweon HK; Christiansen MA; Håkansson K; Williams RM; Ehrlich GD; Sherman DH
    ACS Chem Biol; 2011 Nov; 6(11):1244-56. PubMed ID: 21875091
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and cytotoxic evaluation of some cribrostatin-ecteinascidin analogues.
    Wright BJ; Chan C; Danishefsky SJ
    J Nat Prod; 2008 Mar; 71(3):409-14. PubMed ID: 18278868
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Development of marine-derived anti-cancer compounds].
    Taguchi T
    Gan To Kagaku Ryoho; 2003 May; 30(5):579-88. PubMed ID: 12795086
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Advances in the chemistry and pharmacology of ecteinascidins, a promising new class of anti-cancer agents.
    Manzanares I; Cuevas C; García-Nieto R; Marco E; Gago F
    Curr Med Chem Anticancer Agents; 2001 Nov; 1(3):257-76. PubMed ID: 12678757
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dual inhibition of ATR and ATM potentiates the activity of trabectedin and lurbinectedin by perturbing the DNA damage response and homologous recombination repair.
    Lima M; Bouzid H; Soares DG; Selle F; Morel C; Galmarini CM; Henriques JA; Larsen AK; Escargueil AE
    Oncotarget; 2016 May; 7(18):25885-901. PubMed ID: 27029031
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Zalypsis (PM00104) is a potent inducer of gamma-H2AX foci and reveals the importance of the C ring of trabectedin for transcription-coupled repair inhibition.
    Guirouilh-Barbat J; Antony S; Pommier Y
    Mol Cancer Ther; 2009 Jul; 8(7):2007-14. PubMed ID: 19584237
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Wide-spectrum characterization of trabectedin: biology, clinical activity and future perspectives.
    Vincenzi B; Napolitano A; Frezza AM; Schiavon G; Santini D; Tonini G
    Pharmacogenomics; 2010 Jun; 11(6):865-78. PubMed ID: 20504257
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ecteinascidin 743: a minor groove alkylator that bends DNA toward the major groove.
    Zewail-Foote M; Hurley LH
    J Med Chem; 1999 Jul; 42(14):2493-7. PubMed ID: 10411470
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and cytotoxicity of a novel series of saframycin-ecteinascidin analogs containing tetrahydro-β-carboline moieties.
    Lu X; Pan X; Yang Y; Ji M; Chen X; Xiao Z; Liu Z
    Eur J Med Chem; 2017 Jul; 135():260-269. PubMed ID: 28456034
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.